AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2011

Dec 29, 2011

30071_dirs_2011-12-29_82720e50-c7f7-4f1f-b222-091200128196.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2011-12-27

Reporting Person: FARRELL PETER C (Director, Executive Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-12-27	ResMed Common Stock	G	200000	—	Disposed	526959	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	3317	Indirect
ResMed Common Stock	21391	Indirect
ResMed Common Stock	200000	Indirect
ResMed Common Stock	200000	Indirect
ResMed Common Stock	200000	Indirect

Footnotes

F1: Transaction represents a gift from the Peter C. Farrell Trust to fund the Peter C. Farrell December 2011 Annuity Trust. Dr. Farrell is the trustee of his personal trust, but is not the trustee of the Annuity Trust. Per the terms of the Annuity Trust, 90% of the original value will be transferred to Dr. Farrell at the end of the Trust's first year.